2026 ICD-10-CM Diagnosis Code E72.29Other disorders of urea cycle metabolism
ICD-10-CM Codes›E00–E89›E70-E88›E72
- Billable — Valid for Submission
- Chronic Condition
E72.29 is a billable ICD-10-CM diagnosis code for other disorders of urea cycle metabolism. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). Coders also document this condition as carbamoyl-phosphate synthetase 1 deficiency. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified nutritional and metabolic disorders.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Carbamoyl-phosphate synthetase 1 deficiency
- Deficiency of urease
- Hyperammonemia
- Hyperammonemia, type III
- Inborn error of amino acid metabolism
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Disorder (of) - See Also: Disease;
- urea cycle metabolism - E72.20
- other specified - E72.29
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Disorder(of)
- urea cycle metabolism
- other specified
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Carbamoyl-Phosphate Synthase I Deficiency Disease
a urea cycle disorder manifesting in infancy as lethargy, emesis, seizures, alterations of muscle tone, abnormal eye movements, and an elevation of serum ammonia. the disorder is caused by a reduction in the activity of hepatic mitochondrial carbamoyl-phosphate synthase (ammonia). (menkes, textbook of child neurology, 5th ed, pp50-1)Hyperammonemia
elevated level of ammonia in the blood. it is a sign of defective catabolism of amino acids or ammonia to urea.Hyperlysinemias
a group of inherited metabolic disorders which have in common elevations of serum lysine levels. enzyme deficiencies of alpha-aminoadipic semialdehyde dehydrogenase and the saccharopine dehydrogenases have been associated with hyperlysinemia. clinical manifestations include mental retardation, recurrent emesis, hypotonia, lethargy, diarrhea, and developmental delay. (from menkes, textbook of child neurology, 5th ed, p56)Rett Syndrome
an inherited neurological developmental disorder that is associated with x-linked inheritance and may be lethal in utero to hemizygous males. the affected female is normal until the age of 6-25 months when progressive loss of voluntary control of hand movements and communication skills; ataxia; seizures; autistic behavior; intermittent hyperventilation; and hyperammonemia appear. (from menkes, textbook of child neurology, 5th ed, p199)
Patient EducationClinical
Metabolic Disorders
Metabolism is the process your body uses to get or make energy from the food you eat. Food is made up of proteins, carbohydrates, and fats. Chemicals in your digestive system break the food parts down into sugars and acids, your body's fuel.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert E72.29 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About E72.29Overview
Is E72.29 (Disorders of urea cycle metabolism) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report other disorders of urea cycle metabolism on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What is the ICD-9 equivalent of E72.29?
Under the General Equivalence Mappings, other disorders of urea cycle metabolism converts to ICD-9-CM 270.6 (dis urea cycle metabol). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
